|
|
???tair.name??? >
???browser.page.title.author???
|
"hsu c"???jsp.browse.items-by-author.description???
Showing items 701-725 of 881 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2017 |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2017 |
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis
|
Kuo K.-T.; TZU-PIN LU; Hsiue E.H.-C.;Hsu C.;Tseng L.-H.;Tzu-Pin Lu;Kuo K.-T.; Hsiue E.H.-C.; Hsu C.; Tseng L.-H. |
| 國立成功大學 |
2017 |
Application of high permeability magnetic core sensor for IoTs device
|
Hsu, C.;Huang, Y.;Hsieh, M. |
| 國立成功大學 |
2017 |
Application of Underactuated mechanism motor control in ball and beam system
|
Hsu, C.;Chang, Chang C.;Hsieh, M.;Huang, Y.;Tao, C. |
| 國立成功大學 |
2017 |
Reduction of switching loss of DC to AC power inverter with PID-like fuzzy controller
|
Hsu, C.;Chang, Chang C.;Hsieh, M.;Huang, Y.;Tao, C. |
| 國立成功大學 |
2017 |
Where are the sleeping beauties and princes in educational technology journals?
|
Huang, T.-C.;Jeng, Y.-L.;Hsu, C.;Lai, C.-F. |
| 國立成功大學 |
2016-09 |
Epigenetically regulated caveolin-1 is responsible for hyper-responsiveness to mechanical stimuli and the activation of fibrogenesis-related Runx2 in keloid fibroblasts
|
Hsu, C.; Lin, H.; Harn, I. H.; Ogawa, R.; Lee, Y. J.; McGrath, J.; Tang, M. |
| 國家衛生研究院 |
2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT |
| 國家衛生研究院 |
2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Chen, LT |
| 國立臺灣大學 |
2016 |
Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study
|
Melero, I.; Sangro, B.; Yau, T.; Hsu, C.; Kudo, M.; Crocenzi, T.; Kim, T-Y.; Choo, S-P.; Trojan, J.; Meyer, T.; Welling, T. H., III; Yeo, W.; Chopra, A.; Anderson, J.; Dela Cruz, C.; Lang, L.; Neely, J.; El-Khoueiry, A.; 許駿 |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 臺大學術典藏 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
CHIH-HUNG HSU; Hsu C.; Guo J.-C.; Wu H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Chih-Hung Hsu;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 國家衛生研究院 |
2015-12 |
Towards an endpoint cell motility assay by a microfluidic platform
|
Yeh, C;Tai, W;Lin, C;Juang, D;Wu, C;Chen, Y;Hsu, C |
| 國家衛生研究院 |
2015-12 |
A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer
|
Tang, ST;Liu, TW;Wen, FH;Hsu, C;Chang, YH;Chang, CS;Sung, YC;Hsieh, CI;Chang, SY;Liu, LN;Chiang, MC |
| 國家衛生研究院 |
2015-11 |
Medical care and costs of patients with systemic lupus erythematosus in Taiwan
|
Cheng, J;Huang, C;Hsu, C |
| 國家衛生研究院 |
2015-09 |
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou, DL;Shyue, SK;Lin, LI;Feng, ZR;Liou, JY;Fan, HH;Lee, BS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2015-07 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Liang, PC;Ch'ang, HJ;Hsu, C;Chen, LT;Shih, TTF;Liu, TW |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
| 國立臺灣大學 |
2015 |
LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION
|
Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 許駿; 陳培哲; 陳祈玲 |
| 臺大學術典藏 |
2015 |
Magnetostriction and magnetic loss variation dependent on stress for power transformer core
|
Hsu, C.;Jen, S.;Liu, J.;Fu, C.;Cheng, S.; Hsu, C.; Jen, S.; Liu, J.; Fu, C.; Cheng, S.; CHAO-MING FU |
| 臺大學術典藏 |
2015 |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 國家衛生研究院 |
2014-12-15 |
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis
|
Wu, PC;Lu, JW;Yang, JY;Lin, IH;Ou, DL;Lin, YH;Chou, KH;Huang, WF;Wang, WP;Huang, YL;Hsu, C;Lin, LI;Lin, YM;James Shen, CK;Tzeng, TY |
Showing items 701-725 of 881 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
|
